Related Experiment Videos

[Vertical HIV-I-transmission. II. HIV-diagnosis in a child]

J M Orendi1, S P Geelen, E R de Graeff-Meeder

  • 1Eijkman-Winkler Laboratorium voor Microbiologie, Infectieziekten en Ontsteking, afd. Virologie, Academisch Ziekenhuis Utrecht.

Insights

Early diagnosis of human immunodeficiency virus (HIV) infection in newborns is crucial. Polymerase chain reaction (PCR) testing at four weeks reliably identifies HIV, guiding treatment and preventing unnecessary medication for uninfected infants.

Area of Science:

  • Virology
  • Pediatric Infectious Diseases
  • Diagnostic Technologies

Context:

  • Mother-to-child transmission of human immunodeficiency virus (HIV) necessitates early diagnosis in newborns.
  • Accurate diagnosis is vital for timely and appropriate antiretroviral therapy (ART) in infected infants.
  • Preventing unnecessary medication in HIV-uninfected infants born to infected mothers is a clinical priority.

Purpose:

  • To highlight the importance of early HIV diagnosis in newborns from infected mothers.
  • To emphasize the reliability and utility of polymerase chain reaction (PCR) testing for HIV detection in infants.
  • To outline the implications of PCR results for treatment decisions and prophylaxis.

Summary:

  • Polymerase chain reaction (PCR) technology offers over 95% reliable diagnosis of HIV infection by four weeks of age.
  • A positive PCR result before four weeks necessitates further investigation, including drug resistance testing, and may alter ART.
  • Prophylaxis for Pneumocystis carinii pneumonia is not required if PCR is negative after four weeks.

Impact:

  • Facilitates optimal and individualized antiretroviral therapy for HIV-infected newborns.
  • Prevents unnecessary antiretroviral medication and associated toxicity in HIV-uninfected infants.
  • Improves clinical management and outcomes for infants born to HIV-infected mothers.

Related Concept Videos